Commercialization of methods and reagents for high-throughput single cell analysis
Ended Project Grant Awarded Last action
- Award ID
- R44GM137648
- Recipient
-
Fluent Biosciences Inc. UEI DA7UPTVQMG73
- Awarding agency
-
National Institute of General Medical Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,077,428
Award facts
- Assistance listing
- 93.859 Biomedical Research and Research Training
- Completion date
- Place of performance
- Massachusetts, USA
Award details come from USAspending.gov.
Description
- Abstract
- Single-cell RNA sequencing (SCRNASEQ) provides unprecedented insight into the gene regulatory pathways of living cells in complex tissues. Fluent biosciences has developed pretemplated instant partitioning for single-cell RNA sequencing (PIPSEQ) that eliminates the cost and complexity of bespoke microfluidics and instrumentation and features a simple, flexible workflow that can be implemented in any laboratory setting. With phase I sbir support (1 R43 GM137648-01A1) we have demonstrated that PIPSEQ is intrinsically scalable and is capable of capturing from hundreds to millions of cells in a single reaction. The advent of new, high capacity, and low cost sequencing modalities such as that developed by ultima genomics makes high cell-input single cell transcriptomics not only feasible but practical, enabling previously inaccessible experimental modalities. In this proposal, we will expand the capabilities of PIPSEQ single cell analysis to provide simple, scalable, and cost-effective solutions for high cell input applications including deep tissue profiling, multiplexed drug testing, and pooled crispr screening.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$180,622 | |
| Amendment | -$180,622 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | -$1,146,224 | |
| Amendment | -$1,146,224 | |
| Amendment | $1,146,224 | |
| Amendment | $1,146,224 | |
| Amendment | $1,146,224 | |
| Amendment | $1,146,224 | |
| Original award | $1,146,224 |
Show all 13
Quick answers
Who received award R44GM137648?
R44GM137648 was awarded to Fluent Biosciences Inc. by National Institute of General Medical Sciences (National Institutes of Health) on August 1, 2020.
How much is award R44GM137648 worth?
$3,077,428 has been obligated on R44GM137648.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award